• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型糖尿病患者的心肌功能障碍和慢性心力衰竭:一项长达 7 年的前瞻性队列研究。

Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: a 7-year prospective cohort study.

机构信息

Department of Coronary Disease, Jagiellonian University School of Medicine, John Paul II Hospital, Prądnicka 80, 31-202, Krakow, Poland,

出版信息

Acta Diabetol. 2013 Aug;50(4):597-606. doi: 10.1007/s00592-013-0455-0. Epub 2013 Jan 30.

DOI:10.1007/s00592-013-0455-0
PMID:23358920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3778905/
Abstract

The aim of the study is to evaluate the prevalence and incidence of myocardial dysfunction (MD) and heart failure (HF) in long-lasting (≥10 years) type 1 diabetes without cardiovascular disorders or with hypertension or coronary heart disease (CHD). The study included 1,685 patients with type 1 diabetes (mean baseline age, 51 years; diabetes duration, 36 years). In all patients, echocardiography was performed, NT-proBNP levels were measured, and clinical symptoms were evaluated. A 7-year follow-up was conducted to monitor systolic and diastolic manifestations of MD and HF. At the end of the follow-up period, the prevalence of HF in the entire group was 3.7 %, and the incidence was 0.02 % per year. The prevalence of MD was 14.5 % and the incidence -0.1 % per year. MD and HF were observed only in hypertensive or CHD patients. At baseline, subjects with diastolic HF constituted 85 % of the HF population and those with systolic HF the remaining 15 %. Baseline HF predictors included age, diabetes duration, HbA1c levels, CHD, systolic blood pressure >140 mmHg, and GFR <60 mL/min/1.73 m(2). In patients with type 1 diabetes, MD and HF occurred only when diabetes coexisted with cardiovascular disorders affecting myocardial function. The prevalence and incidence of HF in patients with hypertension and CHD were relatively low. While the cause of this observation remains uncertain, it could probably be explained, at least partially, by the cardioprotective effect of concomitant treatment.

摘要

本研究旨在评估无心血管疾病或合并高血压或冠心病的长期(≥10 年)1 型糖尿病患者心肌功能障碍(MD)和心力衰竭(HF)的患病率和发病率。该研究纳入了 1685 名 1 型糖尿病患者(平均基线年龄为 51 岁,糖尿病病程为 36 年)。所有患者均接受了超声心动图检查、NT-proBNP 水平测定和临床症状评估。进行了 7 年的随访以监测 MD 和 HF 的收缩和舒张表现。随访期末,全组 HF 的患病率为 3.7%,发病率为每年 0.02%。MD 的患病率为 14.5%,发病率为每年 0.1%。MD 和 HF 仅见于高血压或 CHD 患者。基线时,舒张性 HF 患者占 HF 人群的 85%,收缩性 HF 患者占 15%。HF 的基线预测因素包括年龄、糖尿病病程、HbA1c 水平、CHD、收缩压>140mmHg 和 GFR<60mL/min/1.73m2。在 1 型糖尿病患者中,只有当糖尿病合并影响心肌功能的心血管疾病时才会发生 MD 和 HF。高血压和 CHD 患者的 HF 患病率和发病率相对较低。虽然这种观察结果的原因尚不清楚,但至少可以部分解释为同时进行的治疗具有心脏保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0075/3778905/12959ddcb87b/592_2013_455_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0075/3778905/12959ddcb87b/592_2013_455_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0075/3778905/12959ddcb87b/592_2013_455_Fig1_HTML.jpg

相似文献

1
Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: a 7-year prospective cohort study.1 型糖尿病患者的心肌功能障碍和慢性心力衰竭:一项长达 7 年的前瞻性队列研究。
Acta Diabetol. 2013 Aug;50(4):597-606. doi: 10.1007/s00592-013-0455-0. Epub 2013 Jan 30.
2
Left ventricular remodeling and heart failure in diabetic patients treated with primary angioplasty for acute myocardial infarction.糖尿病患者急性心肌梗死接受直接血管成形术治疗后的左心室重构与心力衰竭
Circulation. 2004 Oct 5;110(14):1974-9. doi: 10.1161/01.CIR.0000143376.64970.4A. Epub 2004 Sep 27.
3
[Heart failure prevalence and predictors in Turkey: HAPPY study].[土耳其心力衰竭患病率及预测因素:HAPPY研究]
Turk Kardiyol Dern Ars. 2012 Jun;40(4):298-308. doi: 10.5543/tkda.2012.65031.
4
[Chronic heart failure].[慢性心力衰竭]
Cas Lek Cesk. 2015;154(6):260-8.
5
Age at menarche and heart failure risk: The EPIC-NL study.初潮年龄与心力衰竭风险:EPIC-NL 研究。
Maturitas. 2020 Jan;131:34-39. doi: 10.1016/j.maturitas.2019.10.003. Epub 2019 Nov 5.
6
Predictors of incident heart failure in a large insured population: a one million person-year follow-up study.在一个大型参保人群中预测心力衰竭事件的发生:一项为期一百万人年的随访研究。
Circ Heart Fail. 2010 Nov;3(6):698-705. doi: 10.1161/CIRCHEARTFAILURE.110.938175. Epub 2010 Aug 26.
7
Impact of diabetes on heart failure incidence in adults with ischemic heart disease.糖尿病对缺血性心脏病成年人心力衰竭发病率的影响。
J Diabetes Complications. 2017 Nov;31(11):1597-1601. doi: 10.1016/j.jdiacomp.2017.07.011. Epub 2017 Aug 3.
8
The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study.N端前脑钠肽及超声心动图在筛查心力衰竭高危人群无症状性左心室功能不全中的作用。PROBE-HF研究。
J Card Fail. 2009 Jun;15(5):377-84. doi: 10.1016/j.cardfail.2008.12.002. Epub 2009 Jan 21.
9
Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.高敏肌钙蛋白I与N末端B型利钠肽原联合检测可预测左心室射血分数保留的高危高血压患者未来因心力衰竭住院的情况。
Heart Vessels. 2017 Jul;32(7):880-892. doi: 10.1007/s00380-017-0948-9. Epub 2017 Feb 2.
10
Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.充血性心力衰竭合并孤立性左心室舒张功能障碍患者的患病率、临床特征、生活质量及预后
J Am Soc Echocardiogr. 2004 Mar;17(3):253-61. doi: 10.1016/j.echo.2003.11.002.

引用本文的文献

1
Identification and validation of endoplasmic reticulum stress-related diagnostic biomarkers for type 1 diabetic cardiomyopathy based on bioinformatics and machine learning.基于生物信息学和机器学习的1型糖尿病性心肌病内质网应激相关诊断生物标志物的鉴定与验证
Front Endocrinol (Lausanne). 2025 Mar 18;16:1478139. doi: 10.3389/fendo.2025.1478139. eCollection 2025.
2
Novel insights into the central protective role of ACE2 in diabetic cardiomyopathy: from underlying signaling pathways to therapeutic perspectives.血管紧张素转换酶2(ACE2)在糖尿病性心肌病中的核心保护作用新见解:从潜在信号通路到治疗前景
Mol Cell Biochem. 2025 Jun;480(6):3535-3551. doi: 10.1007/s11010-024-05196-6. Epub 2025 Feb 10.
3

本文引用的文献

1
Can augmentation index substitute aortic pulse wave velocity in the assessment of central arterial stiffness in type 1 diabetes?在 1 型糖尿病患者的中心动脉僵硬度评估中,增强指数能否替代主动脉脉搏波速度?
Acta Diabetol. 2012 Dec;49 Suppl 1:S253-7. doi: 10.1007/s00592-012-0433-y. Epub 2012 Oct 2.
2
Predictors of diabetic cardiomyopathy in asymptomatic patients with type 2 diabetes.2型糖尿病无症状患者糖尿病性心肌病的预测因素
Int J Cardiol. 2012 Apr 19;156(2):219-21. doi: 10.1016/j.ijcard.2012.01.052. Epub 2012 Feb 13.
3
Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study.
Empagliflozin in diabetic cardiomyopathy: elucidating mechanisms, therapeutic potentials, and future directions.
恩格列净在糖尿病性心肌病中的作用:阐明机制、治疗潜力及未来方向
Mol Biol Rep. 2025 Jan 24;52(1):158. doi: 10.1007/s11033-025-10260-5.
4
Heart failure phenotypes in people with type 1 diabetes.1型糖尿病患者的心力衰竭表型
Diabetes Obes Metab. 2025 Mar;27(3):1588-1590. doi: 10.1111/dom.16133. Epub 2024 Dec 17.
5
Patchouli Alcohol Protects the Heart against Diabetes-Related Cardiomyopathy through the JAK2/STAT3 Signaling Pathway.广藿香醇通过JAK2/STAT3信号通路保护心脏免受糖尿病相关心肌病的侵害。
Pharmaceuticals (Basel). 2024 May 14;17(5):631. doi: 10.3390/ph17050631.
6
The double burden: type 1 diabetes and heart failure-a comprehensive review.双重负担:1 型糖尿病与心力衰竭——全面综述。
Cardiovasc Diabetol. 2024 Feb 12;23(1):65. doi: 10.1186/s12933-024-02136-y.
7
Type 1 diabetes, its complications, and non-ischemic cardiomyopathy: a mendelian randomization study of European ancestry.1 型糖尿病、其并发症和非缺血性心肌病:欧洲血统的孟德尔随机研究。
Cardiovasc Diabetol. 2024 Jan 13;23(1):31. doi: 10.1186/s12933-023-02117-7.
8
Urine-derived stem cell therapy for diabetes mellitus and its complications: progress and challenges.尿源干细胞治疗糖尿病及其并发症:进展与挑战。
Endocrine. 2024 Feb;83(2):270-284. doi: 10.1007/s12020-023-03552-y. Epub 2023 Oct 6.
9
Cardiorenal syndrome and diabetes: an evil pairing.心肾综合征与糖尿病:一对有害组合。
Front Cardiovasc Med. 2023 May 10;10:1185707. doi: 10.3389/fcvm.2023.1185707. eCollection 2023.
10
Heart Failure and Diabetes Mellitus: Dangerous Liaisons.心力衰竭与糖尿病:危险关联
Int J Heart Fail. 2022 Oct 28;4(4):163-174. doi: 10.36628/ijhf.2022.0022. eCollection 2022 Oct.
血糖控制与 20985 例 1 型糖尿病患者心力衰竭的发生:一项观察性研究。
Lancet. 2011 Jul 9;378(9786):140-6. doi: 10.1016/S0140-6736(11)60471-6. Epub 2011 Jun 24.
4
Long-term predictive power of simple function tests for cardiovascular autonomic neuropathy in diabetes: a population-based study.简单的功能测试对糖尿病患者心血管自主神经病变的长期预测能力:一项基于人群的研究。
Acta Diabetol. 2011 Dec;48(4):311-316. doi: 10.1007/s00592-011-0283-z. Epub 2011 Apr 17.
5
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.射血分数保留的心力衰竭:病理生理学、诊断和治疗。
Eur Heart J. 2011 Mar;32(6):670-9. doi: 10.1093/eurheartj/ehq426. Epub 2010 Dec 7.
6
Impaired diastolic function and elevated Nt-proBNP levels in type 1 diabetic patients without overt cardiovascular disease.1 型糖尿病患者无明显心血管疾病时舒张功能受损和 Nt-proBNP 水平升高。
Acta Diabetol. 2013 Apr;50(2):155-61. doi: 10.1007/s00592-010-0235-z. Epub 2010 Nov 12.
7
The diabetic cardiomyopathy.糖尿病性心肌病。
Acta Diabetol. 2011 Sep;48(3):173-81. doi: 10.1007/s00592-010-0180-x. Epub 2010 Mar 3.
8
Cardiac autonomic neuropathy in diabetes: a clinical perspective.糖尿病性心脏自主神经病变:临床视角
Diabetes Care. 2010 Feb;33(2):434-41. doi: 10.2337/dc09-1294.
9
Association of B-type natriuretic Peptide levels with estimated glomerular filtration rate and congestive heart failure.B型利钠肽水平与估算肾小球滤过率及充血性心力衰竭的关联
Clin Med Res. 2010 Mar;8(1):7-12. doi: 10.3121/cmr.2009.867. Epub 2009 Nov 17.
10
Intensive glucose control and macrovascular outcomes in type 2 diabetes.强化血糖控制与 2 型糖尿病的大血管结局。
Diabetologia. 2009 Nov;52(11):2288-98. doi: 10.1007/s00125-009-1470-0. Epub 2009 Aug 5.